- Home
- Primary Care
- Dupilumab: A New Era in Chronic Spontaneous Urticaria Treatment

5d3 min read
Medical Article
Introduction: Chronic spontaneous urticaria (CSU) is a persistent inflammatory skin disorder marked by recurrent, unpredictable episodes of hives (wheals), pruritus, and sometimes angioedema lasting longer than six weeks, affecting up to 0.1% to 1.4% of the global population (1). It significantly impairs quality of life, disrupts sleep, and leads t

Dupilumab: A New Era in Chronic Spontaneous Urticaria Treatment
6 Reached
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments

Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes